Drug class
Nasal Mast Cell Stabilizers
Nasal mast cell stabilizers are a class of locally administered non-steroidal anti-inflammatory agents primarily indicated for the prevention and symptomatic treatment of allergic rhinitis. Read more about Nasal Mast Cell Stabilizers
2 drugs in this class 2 manufacturers
Drugs in Nasal Mast Cell Stabilizers
CROMOLYN SODIUM
Nasal mast cell stabilizers are a class of locally administered non-steroidal anti-inflammatory agents primarily indicated for the prevention and symptomatic treatment of allergic rhinitis.
They function by inhibiting antigen-induced calcium influx across the membranes of sensitized mucosal mast cells, which prevents cellular degranulation and blocks the release of inflammatory mediators such as histamine and leukotrienes.
Exemplified by intranasal cromolyn sodium, these medications serve a predominantly prophylactic therapeutic role against seasonal and perennial allergic rhinoconjunctivitis.
Because they target early-phase mediator release with minimal systemic bioavailability, they provide localized control of nasal pruritus, sneezing, and rhinorrhea without causing systemic side effects.
-
nih.gov
Nasal mast cell stabilizers are a class of locally administered non-steroidal anti-inflammatory agents primarily indicated for the prevention and symptomatic treatment of allergic rhinitis They function by inhibiting antigen-induced calcium influx across the membranes of sensitized mucosal mast cells, which prevents cellular degranulation and blocks the release of inflammatory mediators such as histamine and leukotrienes Exemplified by intranasal cromolyn sodium, these medications serve a predom...
-
nih.gov
Nasal mast cell stabilizers are a class of locally administered non-steroidal anti-inflammatory agents primarily indicated for the prevention and symptomatic treatment of allergic rhinitis
-
nih.gov
They function by inhibiting antigen-induced calcium influx across the membranes of sensitized mucosal mast cells, which prevents cellular degranulation and blocks the release of inflammatory mediators such as histamine and leukotrienes
-
nih.gov
Exemplified by intranasal cromolyn sodium, these medications serve a predominantly prophylactic therapeutic role against seasonal and perennial allergic rhinoconjunctivitis Because they target early-phase mediator release with minimal systemic bioavailability, they provide localized control of nasal pruritus, sneezing, and rhinorrhea without causing systemic side effects
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.